Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung

J Lipid Mediat. 1989 Sep-Oct;1(5):273-82.

Abstract

Endotoxic shock is accompanied by significant increases in PAF-acether synthesis, particularly by the lung. The onset of tissue damage and increases in vascular permeability in the gastrointestinal tract correlate temporally with the changes in PAF-acether synthesis and have previously been shown to be inhibited by PAF-acether antagonists. In the present study, the effects of pretreatment with dexamethasone on endotoxin-induced hemoconcentration and hypotension were examined in the rat. Furthermore, the effects of dexamethasone on PAF-acether synthesis and gastrointestinal vascular permeability following administration of endotoxin were also studied. Pretreatment with dexamethasone resulted in a significant attenuation of endotoxin-induced hemoconcentration, hypotension and damage in the duodenum and stomach. Dexamethasone also significantly reduced PAF-acether synthesis by the lung. However, dexamethasone pretreatment had no significant effect on endotoxin-induced increases in PAF-acether release and vascular permeability in the gastrointestinal tissues. The mechanism of the protective actions of dexamethasone may be related to inhibition of the release of PAF-acether from the lung. PAF released from gastrointestinal tissues likely contributes little to the systemic disturbances in endotoxic shock.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capillary Permeability / drug effects
  • Dexamethasone / pharmacology*
  • Digestive System / blood supply
  • Digestive System / drug effects
  • Digestive System / metabolism
  • Lung / drug effects
  • Lung / metabolism
  • Male
  • Platelet Activating Factor / biosynthesis*
  • Platelet Activating Factor / metabolism
  • Rats
  • Rats, Inbred Strains
  • Shock, Septic / metabolism
  • Shock, Septic / physiopathology
  • Shock, Septic / prevention & control*

Substances

  • Platelet Activating Factor
  • Dexamethasone